Angiogenic Factors Are Associated with Development of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

被引:0
|
作者
聂第敏 [1 ]
吴秋玲 [1 ]
朱夏夏 [1 ]
张然 [1 ]
郑鹏 [1 ]
方俊 [1 ]
游泳 [1 ]
仲照东 [1 ]
夏凌辉 [1 ]
洪梅 [1 ]
机构
[1] Institute of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology
基金
中国国家自然科学基金;
关键词
allogeneic hematopoietic stem cell transplantation; acute graft-versus-host disease; angiogenic factors; endothelial damage;
D O I
暂无
中图分类号
R457.7 [骨髓移植];
学科分类号
100215 ;
摘要
Acute graft-versus-host disease(a GVHD) is a serious complication after allogeneic hematopoietic stem cell transplantation(allo-HSCT). However,the mechanisms of a GVHD are not well understood. We aim to investigate the roles of the three angiogenic factors: angiopoietin-1(Ang-1),Ang-2 and vascular endothelial growth factor(VEGF) in the development of a GVHD. Twenty-one patients who underwent allo-HSCT were included in our study. The dynamic changes of Ang-1,Ang-2 and VEGF were monitored in patients before and after allo-HSCT. In vitro,endothelial cells(ECs) were treated with TNF-α in the presence or absence of Ang-1,and then the Ang-2 level in the cell culture medium and the tubule formation by ECs were evaluated. After allo-HSCT,Ang-1,Ang-2 and VEGF all exhibited significant variation,suggesting these factors might be involved in the endothelial damage in transplantation. Patients with a GVHD had lower Ang-1 level at day 7 but higher Ang-2 level at day 21 than those without a GVHD,implying that Ang-1 may play a protective role in early phase yet Ang-2 is a promotion factor to a GVHD. In vitro,TNF-α promoted the release of Ang-2 by ECs and impaired tubule formation of ECs,which were both weakened by Ang-1,suggesting that Ang-1 may play a protective role in a GVHD by influencing the secretion of Ang-2,consistent with our in vivo tests. It is concluded that monitoring changes of these factors following allo-HSCT might help to identify patients at a high risk for a GVHD.
引用
收藏
页码:694 / 699
页数:6
相关论文
共 50 条
  • [41] Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Xiao-long Wu
    Hai-feng Zhuang
    Yan-na Zhao
    Xiao-ling Yu
    Tie-ying Dai
    Rui-lan Gao
    Chinese Journal of Integrative Medicine, 2020, 26 : 324 - 329
  • [42] The effect of costimulatory moleculars on graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Qiao, Zhenhua
    Ye, Fang
    Zu, Lei
    BLOOD, 2007, 110 (11) : 293B - 294B
  • [43] Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    WU Xiao-long
    ZHUANG Hai-feng
    ZHAO Yan-na
    YU Xiao-ling
    DAI Tie-ying
    GAO Rui-lan
    Chinese Journal of Integrative Medicine, 2020, (05) : 324 - 329
  • [44] Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Wu Xiao-long
    Zhuang Hai-feng
    Zhao Yan-na
    Yu Xiao-ling
    Dai Tie-ying
    Gao Rui-lan
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2020, 26 (05) : 324 - 329
  • [45] Onset of Ocular Graft-Versus-Host Disease Symptoms After Allogeneic Hematopoietic Stem Cell Transplantation
    Shikari, Hasanain
    Amparo, Francisco
    Saboo, Ujwala
    Dana, Reza
    CORNEA, 2015, 34 (03) : 243 - 247
  • [46] Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Tanaka, John
    Young, Rebecca
    Heston, Sarah M.
    Jenkins, Kirsten
    Spees, Lisa
    Sung, Anthony D.
    Corbet, Kelly
    Thompson, Jillian C.
    Bohannon, Lauren
    Martin, Paul L.
    Stokhuyzen, Andre
    Vinesett, Richard
    Ward, Doyle, V
    Bhattarai, Shakti K.
    Bucci, Vanni
    Arshad, Mehreen
    Seed, Patrick C.
    Kelly, Matthew S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (11) : 2053 - 2060
  • [47] Anaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Tanaka, John
    Young, Rebecca
    Spees, Lisa
    Jenkins, Kirsten
    Sung, Anthony D.
    Martin, Paul L.
    Heston, Sarah
    Thompson, Jillian C.
    Seed, Patrick
    Arshad, Mehreen
    Kelly, Matthew
    BLOOD, 2019, 134
  • [48] Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
    Lee, Kyoo-Hyung
    Choi, Seong-Jun
    Lee, Jung-Hee
    Lee, Jung-Shin
    Kim, Woo-Kun
    Lee, Kyu-Bo
    Sohn, Sang-Kyun
    Kim, Jong-Gwang
    Kim, Dong-Hwan
    Seol, Miee
    Lee, Young-Shin
    Lee, Je-Hwan
    HAEMATOLOGICA, 2005, 90 (07) : 939 - 948
  • [49] Clinical and Economic Burden Associated With Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation in Germany
    Holtick, Udo
    Quignot, Nadia
    Kapso-Kapnang, Raissa
    Reichenbach, Dawn
    Kelly, Maebh
    Burrell, Anita
    Zhang, Xiang
    Thiruvillakkat, Kris
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (01) : 191 - 200
  • [50] Ocular Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
    Westeneng, Arnaud C.
    Hettinga, Ymkje
    Lokhorst, Henk
    Verdonck, Leo
    van Dorp, Suzanne
    Rothova, Aniki
    CORNEA, 2010, 29 (07) : 758 - 763